{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:14:45Z","timestamp":1768882485142,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le SIDA et les Hepatites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.talanta.2021.122378","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T02:54:52Z","timestamp":1617072892000},"page":"122378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study"],"prefix":"10.1016","volume":"231","author":[{"given":"Julien","family":"Gomez-Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Foulongne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Laureillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Nagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Mont\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois","family":"Cantaloube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3912-0427","authenticated-orcid":false,"given":"Philippe","family":"Van de Perre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Fournier-Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Mol\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Br\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2021.122378_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-803309-8.00002-1","article-title":"Genetic instability of RNA viruses","author":"Barr","year":"2016","journal-title":"Genome Stability"},{"issue":"9849","key":"10.1016\/j.talanta.2021.122378_bib2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","author":"Gupta","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.talanta.2021.122378_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S1473-3099(17)30702-8","article-title":"HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis","volume":"18","author":"Gupta","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"10.1016\/j.talanta.2021.122378_bib4","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jix089","article-title":"Impact of HIV drug resistance on HIV\/AIDS-Associated mortality, new infections, and antiretroviral therapy program costs in sub\u2013saharan Africa","volume":"215","author":"Phillips","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.talanta.2021.122378_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1473-3099(11)70255-9","article-title":"Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study","volume":"12","author":"Hamers","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"66","key":"10.1016\/j.talanta.2021.122378_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/QAI.0000000000000108","article-title":"Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-Infected patients in South east Asia","volume":"1","author":"Phanuphak","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"11","key":"10.1016\/j.talanta.2021.122378_bib7","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1128\/JCM.01669-13","article-title":"Simultaneous detection of major drug resistance mutations in the protease and reverse transcriptase genes for HIV-1 subtype C by use of a multiplex allele-specific assay","volume":"51","author":"Zhang","year":"2013","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.talanta.2021.122378_bib8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1128\/JCM.02833-15","article-title":"Simultaneous detection of major drug resistance mutations of HIV-1 subtype B viruses from dried blood spot specimens by multiplex allele-specific assay","volume":"54","author":"Zhang","year":"2016","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.talanta.2021.122378_bib9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.jmoldx.2019.02.005","article-title":"Multiplex solid-phase melt curve analysis for the point-of-care detection of HIV-1 drug resistance","volume":"21","author":"Clutter","year":"2019","journal-title":"J. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.talanta.2021.122378_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jmoldx.2015.07.001","article-title":"One-step ligation on RNA amplification for the detection of point mutations","volume":"17","author":"Zhang","year":"2015","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.talanta.2021.122378_bib11","series-title":"PANDAA-monium: Intentional Violations of Conventional qPCR Design Enables Rapid, HIV-1 Subtype-independent Drug Resistance SNP Detection","first-page":"795054","author":"MacLeod","year":"2019"},{"key":"10.1016\/j.talanta.2021.122378_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01045-20","article-title":"Diagnostic accuracy of Pan Degenerative Amplification and Adaptation (PANDAA) assay for HIV-1 drug resistance mutations analysis in low and middle-income countries","author":"Kouamou","year":"2020","journal-title":"J. Clin. Microbiol."},{"issue":"suppl 5","key":"10.1016\/j.talanta.2021.122378_bib13","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/sti.2006.024265","article-title":"Rapid tests for sexually transmitted infections (STIs): the way forward","volume":"82","author":"Peeling","year":"2006","journal-title":"Sex. Transm. Infect."},{"issue":"8","key":"10.1016\/j.talanta.2021.122378_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.tibtech.2017.03.013","article-title":"Multiplexed point-of-care testing \u2013 xPOCT","volume":"35","author":"Dincer","year":"2017","journal-title":"Trends Biotechnol."},{"issue":"3","key":"10.1016\/j.talanta.2021.122378_bib15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1473-3099(13)70250-0","article-title":"Diagnostic point-of-care tests in resource-limited settings","volume":"14","author":"Drain","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.talanta.2021.122378_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.bioeng.10.061807.160524","article-title":"Point-of-Care diagnostics for global health","volume":"10","author":"Yager","year":"2008","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.talanta.2021.122378_bib17","series-title":"OLA-Simple: A Software-Guided HIV-1 Drug Resistance Test for Low-Resource Laboratories","author":"Panpradist","year":"2019"},{"issue":"1","key":"10.1016\/j.talanta.2021.122378_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145962","article-title":"Simplified paper format for detecting HIV drug resistance in clinical specimens by oligonucleotide ligation","volume":"11","author":"Panpradist","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.talanta.2021.122378_bib19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ab.2017.12.008","article-title":"Paper-based detection of HIV-1 drug resistance using isothermal amplification and an oligonucleotide ligation assay","volume":"544","author":"Natoli","year":"2018","journal-title":"Anal. Biochem."},{"issue":"9","key":"10.1016\/j.talanta.2021.122378_bib20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1097\/QAD.0000000000002524","article-title":"Near point-of-care, point-mutation test to detect drug resistance in HIV-1: a validation study in a Mexican cohort","volume":"34","author":"Panpradist","year":"2020","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.talanta.2021.122378_bib21","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1021\/acs.analchem.8b01078","article-title":"Multiplex lateral flow assay for rapid visual blood group genotyping","volume":"90","author":"Gomez-Martinez","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2021.122378_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.aca.2012.03.041","article-title":"Lateral flow dipstick test for genotyping of 15 beta-globin gene (HBB) mutations with naked-eye detection","volume":"727","author":"Papanikos","year":"2012","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.talanta.2021.122378_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cca.2015.04.016","article-title":"Multi-allele DNA biosensor for the rapid genotyping of \u2018nondeletion\u2019 alpha thalassaemia mutations in HBA1 and HBA2 genes by means of multiplex primer extension reaction","volume":"446","author":"Petropoulou","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"10.1016\/j.talanta.2021.122378_bib24","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00216-016-9310-9","article-title":"\u03a4wo-panel molecular testing for genetic predisposition for thrombosis using multi-allele visual biosensors","volume":"408","author":"Fountoglou","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.talanta.2021.122378_bib25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12879-019-4389-1","article-title":"Trend of HIV transmitted drug resistance before and after implementation of HAART regimen restriction in the treatment of HIV-1 infected patients in southern Taiwan","volume":"19","author":"Weng","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.talanta.2021.122378_bib26","series-title":"HIV Drug Resistance Report 2019","year":"2019"},{"issue":"5","key":"10.1016\/j.talanta.2021.122378_bib27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/01.aids.0000216363.36786.2b","article-title":"B.H.I.V.W.G. International Non Subtype, HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes","volume":"20","author":"Rhee","year":"2006","journal-title":"AIDS (London, England)"},{"issue":"Supplement_1","key":"10.1016\/j.talanta.2021.122378_bib28","first-page":"S51","article-title":"Shafer, rationale and uses of a public HIV drug\u2010resistance database","volume":"194","author":"Robert","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.talanta.2021.122378_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/COH.0000000000000344","article-title":"Future technologies for monitoring HIV drug resistance and cure","volume":"12","author":"Parikh","year":"2017","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"5","key":"10.1016\/j.talanta.2021.122378_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment\u2013naive patients significantly impact treatment outcomes","volume":"199","author":"Simen","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.talanta.2021.122378_bib31","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1016\/S2352-3018(18)30177-2","article-title":"Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study","volume":"5","author":"Inzaule","year":"2018","journal-title":"The Lancet HIV"},{"key":"10.1016\/j.talanta.2021.122378_bib32","series-title":"90\u201390\u201390 - an Ambitious Treatment Target to Help End the AIDS Epidemic","year":"2017"},{"issue":"4","key":"10.1016\/j.talanta.2021.122378_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001810","article-title":"Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis","volume":"12","author":"Rhee","year":"2015","journal-title":"PLoS Med."}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991402100299X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003991402100299X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:47:53Z","timestamp":1758545273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003991402100299X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":33,"alternative-id":["S003991402100299X"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2021.122378","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2021.122378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122378"}}